Last updated: July 21, 2024
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
3
Condition
Low Blood Pressure (Hypotension)
Treatment
Prilocaine
Bupivacaine
Clinical Study ID
NCT06165679
N-439-2023
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients aged 65 years old and above.
Both genders.
Patients scheduled to undergo endoscopic urological surgeries.
ASA I and II class.
Exclusion
Exclusion Criteria:
Patient refusal.
Known local anesthetic (LA) allergy.
Bleeding disorders.
Skin lesions or infections at site of needle insertion.
Hypertensive patients.
Patients candidate for transurethral resection of the prostate
ASA III and VI class
Study Design
Total Participants: 112
Treatment Group(s): 2
Primary Treatment: Prilocaine
Phase: 3
Study Start date:
December 20, 2023
Estimated Completion Date:
August 15, 2024
Connect with a study center
Kasr Alaini hospital
Cairo,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.